<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<title>A3366</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Albertus Extra Bold";
	panose-1:2 14 8 2 4 3 4 2 2 4;}
@font-face
	{font-family:Marlett;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	background:navy;
	font-size:12.0pt;
	font-family:"Tahoma",sans-serif;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-link:"Balloon Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:9.0pt;
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
span.11ptChar
	{mso-style-name:11ptChar;
	font-family:"Times New Roman",serif;}
span.BillHead
	{mso-style-name:BillHead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillHeading2
	{mso-style-name:BillHeading2;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillHeadUnBold
	{mso-style-name:BillHeadUnBold;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
span.BillLanguage
	{mso-style-name:BillLanguage;
	font-family:"Times New Roman",serif;
	font-style:italic;}
p.bpuBill, li.bpuBill, div.bpuBill
	{mso-style-name:bpuBill;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:26.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuHeadSpon, li.bpuHeadSpon, div.bpuHeadSpon
	{mso-style-name:bpuHeadSpon;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.bpuHeadSponChar
	{mso-style-name:bpuHeadSponChar;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuIntro, li.bpuIntro, div.bpuIntro
	{mso-style-name:bpuIntro;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.bpuLegislature, li.bpuLegislature, div.bpuLegislature
	{mso-style-name:bpuLegislature;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:24.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuNormText, li.bpuNormText, div.bpuNormText
	{mso-style-name:bpuNormText;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuReprint, li.bpuReprint, div.bpuReprint
	{mso-style-name:bpuReprint;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:22.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.bpuSponsor, li.bpuSponsor, div.bpuSponsor
	{mso-style-name:bpuSponsor;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuState, li.bpuState, div.bpuState
	{mso-style-name:bpuState;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:32.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
span.charMarlett
	{mso-style-name:charMarlett;
	font-family:Marlett;}
p.ElevenPt, li.ElevenPt, div.ElevenPt
	{mso-style-name:ElevenPt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage, li.FronterPage, div.FronterPage
	{mso-style-name:FronterPage;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage12pt, li.FronterPage12pt, div.FronterPage12pt
	{mso-style-name:FronterPage12pt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageBillHeading, li.FronterPageBillHeading, div.FronterPageBillHeading
	{mso-style-name:FronterPageBillHeading;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FronterPageTBox2, li.FronterPageTBox2, div.FronterPageTBox2
	{mso-style-name:FronterPageTBox2;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageTextBox, li.FronterPageTextBox, div.FronterPageTextBox
	{mso-style-name:FronterPageTextBox;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.FronterSameAs, li.FronterSameAs, div.FronterSameAs
	{mso-style-name:FronterSameAs;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.HangingAnAct, li.HangingAnAct, div.HangingAnAct
	{mso-style-name:HangingAnAct;
	mso-style-link:"HangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.HangingAnActChar
	{mso-style-name:"HangingAnAct Char";
	mso-style-link:HangingAnAct;
	letter-spacing:.2pt;}
span.Para10pt
	{mso-style-name:Para10pt;
	font-family:"Times New Roman",serif;}
p.Pg2Footer, li.Pg2Footer, div.Pg2Footer
	{mso-style-name:Pg2Footer;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:8.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.StyleFronterPage11pt, li.StyleFronterPage11pt, div.StyleFronterPage11pt
	{mso-style-name:"Style FronterPage + 11 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.StyleFronterPageLoweredby3pt, li.StyleFronterPageLoweredby3pt, div.StyleFronterPageLoweredby3pt
	{mso-style-name:"Style FronterPage + Lowered by  3 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	position:relative;
	top:3.0pt;}
p.StyleFronterSameAsPatternSolid100White, li.StyleFronterSameAsPatternSolid100White, div.StyleFronterSameAsPatternSolid100White
	{mso-style-name:"Style FronterSameAs + Pattern\: Solid \(100%\) \(White\)";
	margin:0in;
	margin-bottom:.0001pt;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Whereas
	{mso-style-name:Whereas;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.Style10pt
	{mso-style-name:"Style 10 pt";
	font-family:"Times New Roman",serif;}
p.FronterPageNOCAPS, li.FronterPageNOCAPS, div.FronterPageNOCAPS
	{mso-style-name:FronterPageNOCAPS;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuWpGraphic, li.bpuWpGraphic, div.bpuWpGraphic
	{mso-style-name:bpuWpGraphic;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.sponUdate, li.sponUdate, div.sponUdate
	{mso-style-name:sponUdate;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.fronterpagebillhead
	{mso-style-name:fronterpagebillhead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FPHangingAnAct, li.FPHangingAnAct, div.FPHangingAnAct
	{mso-style-name:FPHangingAnAct;
	mso-style-link:"FPHangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.4in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.FPHangingAnActChar
	{mso-style-name:"FPHangingAnAct Char";
	mso-style-link:FPHangingAnAct;
	letter-spacing:.2pt;}
span.LeftBrackt
	{mso-style-name:LeftBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.RightBrackt
	{mso-style-name:RightBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.BoldItal
	{mso-style-name:BoldItal;
	font-weight:bold;
	font-style:italic;}
p.HangingSup, li.HangingSup, div.HangingSup
	{mso-style-name:HangingSup;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableBottom, li.HangingTableBottom, div.HangingTableBottom
	{mso-style-name:HangingTableBottom;
	margin-top:0in;
	margin-right:1.0in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableTop, li.HangingTableTop, div.HangingTableTop
	{mso-style-name:HangingTableTop;
	margin-top:0in;
	margin-right:.5in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-link:"Balloon Text";
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
.MsoChpDefault
	{font-size:10.0pt;}
 /* Page Definitions */
 @page WordSection1
	{size:8.5in 14.0in;
	margin:1.5in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
@page WordSection2
	{size:8.5in 14.0in;
	margin:1.0in 113.75pt 1.0in 113.75pt;}
div.WordSection2
	{page:WordSection2;}
@page WordSection3
	{size:8.5in 14.0in;
	margin:1.0in 1.75in 1.3in 2.0in;}
div.WordSection3
	{page:WordSection3;}
-->
</style>

</head>

<body lang=EN-US>

<div class=WordSection1>

<p class=bpuBill><a name=bpuFrontPg></a>ASSEMBLY, No. 3366 </p>

<p class=bpuWpGraphic><b><span style='font-size:32.0pt;line-height:120%;
font-family:"Arial",sans-serif;letter-spacing:0pt'>STATE OF NEW JERSEY</span></b></p>

<p class=bpuLegislature>221st LEGISLATURE</p>

<p class=bpuWpGraphic>  </p>

<p class=bpuIntro>INTRODUCED JANUARY 29, 2024</p>

<p class=bpuIntro>&nbsp;</p>

</div>

<span style='font-size:11.0pt;line-height:120%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:auto'>
</span>

<div class=WordSection2>

<p class=bpuIntro>&nbsp;</p>

<p class=bpuSponsor>Sponsored by:</p>

<p class=bpuSponsor>Assemblywoman  SHANIQUE SPEIGHT</p>

<p class=bpuSponsor>District 29 (Essex and Hudson)</p>

<p class=bpuSponsor>Assemblywoman  ELIANA PINTOR MARIN</p>

<p class=bpuSponsor>District 29 (Essex and Hudson)</p>

<p class=bpuSponsor>Assemblywoman  VERLINA REYNOLDS-JACKSON</p>

<p class=bpuSponsor>District 15 (Hunterdon and Mercer)</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>Co-Sponsored by:</p>

<p class=bpuSponsor>Assemblywoman Carter</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>SYNOPSIS</p>

<p class=bpuNormText>     Establishes Womens Menstrual Health Program to
identify and assist patients with symptoms related to endometriosis and
polycystic ovary syndrome. </p>

<p class=bpuNormText>&nbsp;</p>

<p class=bpuSponsor>CURRENT VERSION OF TEXT </p>

<p class=bpuNormText>     As introduced.</p>

<p class=bpuNormText>   </p>

</div>

<span style='font-size:12.0pt;line-height:120%;font-family:"Times New Roman",serif;
letter-spacing:.2pt'><br clear=all style='page-break-before:always'>
</span>

<div class=WordSection3>

<p class=HangingAnAct style='line-height:150%'><span class=BillHead>An Act</span><span
class=HangingAnActChar> establishing a Womens Menstrual Health Program and
supplementing Title 26 of the Revised Statutes.</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     <span class=BillHeading2>Be It
Enacted </span><span class=BillLanguage>by the Senate and General Assembly of
the State of New Jersey:</span></p>

<p class=MsoNormal style='line-height:150%'><span class=BillLanguage><span
style='font-style:normal'>&nbsp;</span></span></p>

<p class=MsoNormal style='line-height:150%'>     1.  As used in this act,
endometriosis means a systemic disease generally occurring in menstruating individuals,
which may also occur in pre-menarcheal and post-menopausal individuals.</p>

<p class=MsoNormal style='line-height:150%'><span class=BillLanguage><span
style='font-style:normal'>&nbsp;</span></span></p>

<p class=MsoNormal style='line-height:150%'>     2.    The Legislature finds
and declares that:</p>

<p class=MsoNormal style='line-height:150%'>     a.     According to the United
States Department of Health and Human Servicess Office on Womens Health,
endometriosis may affect more than 11 percent of American women between the
ages of 15 and 44, which is approximately 6.5 million women in the United
States alone;</p>

<p class=MsoNormal style='line-height:150%'>     b.    According to the Mayo
Clinic, endometriosis is an often painful disorder in which tissue similar to
the tissue that normally lines the inside of a womans uterus, called the
endometrium, grows outside the uterus; </p>

<p class=MsoNormal style='line-height:150%'>     c.     In patients who have
endometriosis, the endometrial-like tissue thickens, breaks down, and bleeds
with each menstrual cycle. However, since this tissue has no way to exit the
body, it becomes trapped; </p>

<p class=MsoNormal style='line-height:150%'>     d.    When endometriosis
impacts the ovaries, cysts called endometriomas may form.  Surrounding tissue
can become irritated, eventually developing scar tissue and adhesions that can
cause pelvic tissues and organs to stick to each other; </p>

<p class=MsoNormal style='line-height:150%'>     e.     The primary symptom of
endometriosis is pelvic pain.  While many women experience cramping during
their menstrual periods, those patients with endometriosis typically describe
menstrual pain that is much worse than typical, and this pain may increase over
time;</p>

<p class=MsoNormal style='line-height:150%'>     f.     Symptoms of endometriosis
include: painful periods, called dysmenorrhea, pain with intercourse, pain with
bowel movements or urination, excessive bleeding, infertility, fatigue,
diarrhea, constipation, bloating, and nausea; </p>

<p class=MsoNormal style='line-height:150%'>     g.    Ovarian cancer occurs at
higher than expected rates in those who have endometriosis.  Although rare,
another type of cancer called endometriosis-associated adenocarcinoma can
develop later in life in those who have had endometriosis;</p>

<p class=MsoNormal style='line-height:150%'>     h.    According to the Centers
for Disease Control and Prevention, polycystic ovary syndrome (PCOS) is one of
the most common causes of female infertility, affecting six to 12 percent of
women of reproductive age in the United States, or as many as five million
women; </p>

<p class=MsoNormal style='line-height:150%'>     i.     This life-long health
condition continues far beyond the child-bearing years and involves other
serious health complications; </p>

<p class=MsoNormal style='line-height:150%'>     j.     Women with PCOS are
often insulin resistant, which means that their bodies can make insulin but are
unable to use it effectively.  Insulin resistance increases a patients risk
for Type 2 diabetes; </p>

<p class=MsoNormal style='line-height:150%'>     k.    More than half of women
with PCOS develop type 2 diabetes by age 40.  PCOS patients can also develop
gestational diabetes which puts the pregnancy and baby at risk and can lead to
type 2 diabetes later in life for both mother and child;</p>

<p class=MsoNormal style='line-height:150%'>     l.     PCOS patients also have
higher levels of androgens which can stop eggs from being released and cause
irregular periods, acne, thinning scalp hair, and excess hair growth on the
face and body;</p>

<p class=MsoNormal style='line-height:150%'>     m.   Women with PCOS are at
higher risk of heart disease, and this risk increases with age.  Those with
PCOS can also experience:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   high blood pressure,
which can damage the heart, brain, and kidneys;</p>

<p class=MsoNormal style='line-height:150%'>     (2)   high LDL, or bad
cholesterol, and low HDL, or good<b><span style='font-family:"Albertus Extra Bold",sans-serif'>
</span></b>cholesterol, which increases the risk for heart disease;</p>

<p class=MsoNormal style='line-height:150%'>     (3)   obstructive sleep apnea,
a disorder that causes breathing to stop during sleep and raises the risk for
heart disease and type 2 diabetes; and</p>

<p class=MsoNormal style='line-height:150%'>     (4)   stroke; </p>

<p class=MsoNormal style='line-height:150%'>     n.    PCOS is also linked to
depression and anxiety; and</p>

<p class=MsoNormal style='line-height:150%'>     o.    Given all of the
increased health risks associated with endometriosis and PCOS and the number of
women impacted by these disorders, it is imperative that the State establish a
Womens Menstrual Health Program within the Department of Health to identify
and assist patients, who have displayed symptoms related to menstrual
disorders.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     3.    a. The Commissioner of
Health shall establish in the Department of Health a Womens Menstrual Health
Program to identify and assist patients, who have displayed symptoms related to
menstrual disorders. </p>

<p class=MsoNormal style='line-height:150%'>     b. The Department of Health
shall, in accordance with evidence-based industry best practices, guidelines,
and screening tools, as recommended by the American College of Obstetricians
and Gynecologists or another nationally-recognized body as may be designated by
the commissioner:</p>

<p class=MsoNormal style='line-height:150%'>     (1)  contract with appropriate
health care providers to identify, assist, provide screenings for endometriosis
and polycystic ovary syndrome, and provide any necessary treatment, follow-up
care, and referrals, as appropriate, to patients, who have displayed symptoms
related to menstrual disorders;</p>

<p class=MsoNormal style='line-height:150%'>     (2)  provide education and
training to health care providers, hospital staff who encounter patients in
emergent situations, and the public concerning menstrual health, menstrual
health screening, and menstrual health care; and</p>

<p class=MsoNormal style='line-height:150%'>     (3)  provide on the Department
of Healths Internet website information and resources for health care
providers and patients, which shall include, but not be limited to:</p>

<p class=MsoNormal style='line-height:150%'>     (a)  evidence-based clinical
practice guidelines for health care providers for the screening, referral,
treatment, and follow-up care of patients, who have displayed symptoms related
to menstrual disorders; and </p>

<p class=MsoNormal style='line-height:150%'>     (b)  educational materials for
health care providers and the public concerning menstrual disorders,
menstruation-related disorders, and menstruation-related conditions.</p>

<p class=MsoNormal style='line-height:150%'>     c. The commissioner shall
collect information on patients , who were screened pursuant to paragraph (1)
of subsection b. of this section, in a standardized manner and develop a system
for quality assurance which includes the periodic assessment of indicators that
are measurable, functional, and appropriate to the conditions for which
patients, who have displayed symptoms related to menstrual disorders, shall be
identified as potentially having endometriosis and PCOS pursuant to paragraph
(1) of subsection b. of this section.  The commissioner shall have the
authority to use the information collected to provide follow-up care to , and
appropriate referrals for, patients with positive diagnoses through the health
care providers contracted pursuant to paragraph (1) of subsection b. of this
section .  Information on patients compiled pursuant to this section shall be
used by the department and agencies designated by the commissioner for the
purposes of carrying out this act, but otherwise the information shall be
confidential and not divulged or made public so as to disclose the identity of
any person to which it relates, except as provided by law. </p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     4.    The Department of Health
shall, in accordance with the Administrative Procedure Act, P.L.1968, c.410 (C.52:14B-1
et seq.), adopt any rules and regulations as the department deems necessary to
implement the provisions of this act.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     5.    This act shall take
effect on the 30th day following enactment, except that the Commissioner of
Health may take such anticipatory action in advance as shall be necessary for
its implementation. </p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal align=center style='text-align:center;line-height:150%'>STATEMENT</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'><span style='line-height:150%;
letter-spacing:0pt'>      This bill establishes a Womens Menstrual Health
Program to identify and assist patients, who have displayed symptoms related to
menstrual disorders, for endometriosis and polycystic ovary syndrome (PCOS). </span></p>

<p class=MsoNormal style='line-height:150%'><span style='line-height:150%;
letter-spacing:0pt'>      Endometriosis may affect more than 11 percent of American
women between the ages of 15 and 44, which is approximately 6.5 million women
in the United States alone.  Symptoms include severe pelvic and menstrual pain,
infertility, painful bowel movements, pain with intercourse, excessive
bleeding, and nausea. </span></p>

<p class=MsoNormal style='line-height:150%'><span style='line-height:150%;
letter-spacing:0pt'>      PCOS is one of the most common causes of female
infertility, affecting six to 12 percent of women of reproductive age in the
United States (as many as five million women).  This life-long health condition
continues far beyond the child-bearing years and involves other serious health
complications, including insulin resistance, gestational diabetes, and heart
disease.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='line-height:150%;
letter-spacing:0pt'>      Given the increased health risks associated with
endometriosis and PCOS and the number of women impacted by these disorders, the
bill establishes a Womens Menstrual Health Program in the Department of Health
(department), to identify and assist patients, who have displayed symptoms
related to menstrual disorders, for endometriosis and PCOS. </span></p>

<p class=MsoNormal style='line-height:150%'><span style='line-height:150%;
letter-spacing:0pt'>      The bill requires the department, in accordance with
evidence-based industry best practices, guidelines, and screening tools, as
recommended by the American College of Obstetricians and Gynecologists or
another nationally-recognized body as may be designated by the Commissioner of
Health, to:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='line-height:150%;
letter-spacing:0pt'>      (1)   contract with appropriate health care providers
to identify, assist, provide screenings for endometriosis and polycystic ovary
syndrome, and provide any necessary treatment, follow-up care, and referrals,
as appropriate, to patients, who have displayed symptoms related to menstrual
disorders;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='line-height:150%;
letter-spacing:0pt'>      (2)  provide education and training to health care
providers, hospital staff who encounter patients in emergent situations, and
the public concerning menstrual health, menstrual health screening, and
menstrual health care; and</span></p>

<p class=MsoNormal style='line-height:150%'><span style='line-height:150%;
letter-spacing:0pt'>      (3)  provide on the departments Internet website
information and resources for health care providers and patients, which will
include, but not be limited to:  evidence-based clinical practice guidelines
for health care providers for the screening, referral, treatment, and follow-up
care of patients, who have displayed symptoms related to menstrual disorders;
and educational materials for health care providers and the public concerning
menstrual disorders, menstruation-related disorders, and menstruation-related
conditions.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='line-height:150%;
letter-spacing:0pt'>      The bill requires the commissioner to collect
information on patients, who were screened pursuant to the bill, in a
standardized manner and develop a system for quality assurance which includes
the periodic assessment of indicators that are measurable, functional, and
appropriate to the conditions for which patients, who have displayed symptoms
related to menstrual disorders, will be</span><b><sup><span style='line-height:
150%;font-family:"Albertus Extra Bold",sans-serif'> </span></sup></b><span
style='line-height:150%;letter-spacing:0pt'>screened pursuant to the bill.  The
commissioner will have the authority to use the information collected to
provide follow-up care to, and appropriate referrals for, patients with
positive diagnoses through the health care </span><br clear=all
style='page-break-before:always'>
<span style='line-height:150%;letter-spacing:0pt'>providers contracted pursuant
to the bill.  Information on patients compiled will be used by the department
and agencies designated by the commissioner for the purposes of carrying out
the provisions of the bill, but otherwise the information will be confidential
and not divulged or made public so as to disclose the identity of any person to
which it relates, except as provided by law.</span> </p>

</div>

</body>

</html>
